Amy W. Zhou, MD

Amy W. Zhou, MD

Associate Professor


  • Hematology Division
    Mail Stop 8125-0022-01, Washington University, 660 South Euclid Avenue, St. Louis, MO 63110 (mail)
  • Suite 1101 Wohl Hospital (office)

Research Interest: MPN; Myelofibrosis; Leukocytosis; Polycythemia; Thrombocytosis; Anemia; Cytopenias

Research: I have a specific clinical interest in myeloproliferative neoplasms such as CML, PV, ET, and myelofibrosis. I also have an interest in hyperproliferative anemias and cytopenias.

I am interested in conducting clinical research focusing on the development of novel agents for the treatment of MPNs such as myelofibrosis. I am currently working in collaboration with Dr. Stephen Oh and his lab.



  • 2009-2005: MD, Wayne State University School of Medicine, Detroit, MI
  • 2005-2001: BS (summa cum laude), University of Michigan, Ann Arbor, MI

Post-Graduate Training

  • 2016-2013: Fellowship in Hematology-Oncology, Washington University Medical School, St. Louis, MO
  • 2012-2009: Residency, Emory University School of Medicine, Atlanta, GA

Academic Positions

  • 2023-present: Associate Professor, Division of Hematology, Washington University Medical School, St. Louis, MO
  • 2019-2023: Assistant Professor, Division of Hematology, Washington University Medical School, St. Louis, MO
  • 2019-2016: Instructor, Division of Hematology, Washington University Medical School, St. Louis, MO
  • 2013-2012: Clinical Instructor of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA

University & Hospital Appointments & Committees

  • 2023-present: Chair, Transfusion Committee
  • 2022-present: Recruitment Leader for Hematology, Hem/Onc Fellowship
  • 2021- present: Coach, IM Coaching
  • 2021-present: Member, Siteman Standing Data and Safety Monitoring Board (DSMB)
  • 2018-present: Division of Hematology Lead, Bias Reduction in Internal Medicine (BRIM) Project
  • 2018-present: Member, Transfusion Committee
  • 2017-present: Curriculum Development Leader, Hematology/Oncology Fellowship Program
  • 2017-present: Key Faculty Member, Hematology/Oncology Fellowship

Board Certification

  • 2026-2016: ABIM Board Certified in Medical Oncology
  • 2026-2016: ABIM Board Certified in Hematology
  • 2022-2012: ABIM Board Certified in Internal Medicine

Honors & Awards

  • 2017-2016: American Society of Hematology Clinical Research Training Institute (CRTI) Award
  • 2016 Hemostasis and Thrombosis Research Society (HTRS) Trainee Workshop Award

Editorial Boards

  • 2023-Present: Frontiers in Medicine, Hematology section

Professional Societies

  • American Society of Hematology

Selected Publications

  • Hepcidin is elevated in primary and secondary MF and remains elevated in patients treated with ruxolitinib
    Amy Zhou, Tim Kong, Jared S Fowles, Chun-Ling Jung, Maggie J Allen, Daniel A C Fisher, Mary Fulbright, Elizabeta Nemeth, Tomas Ganz, Stephen T Oh
    Br J Haematol. 2022 May;197(4):e49-e52
  • Roxadustat for treatment of anemia in patients with lower-risk MDS: open-label dose-selection, lead in stage of a phase 3 study
    David H Henry, John Glaspy, Rosemary Harrup, Moshe Mittelman, Amy Zhou, Hetty E Carraway, Charles Bradley, Gopal Saha, Katharina Modelska, Pamela Bartels, Robert Leong, Kin-Hung P Yu
    Am J Hematol. 2022 Feb 1;97(2):174-184
  • Clinical improvement of JAK2 inhibition in Chuvash polycythemia 
    Amy Zhou, Eric M Knoche, Elizabeth K Engle, Makiko Ban-Hoefen, Charu Kaiwar, Stephen T Oh
    N Engl J Med. 2016 Aug 4;375(5):494-6
  • Outcomes of platelet transfusion in patients with TTP: a retrospective case series study
    Amy Zhou, Rohtesh S Mehta, Roy E Smith
    Ann Hematol. 2015 Mar;94(3):467-72
  • Is the incidence of heparin-induced thrombocytopenia affected by the increased use of heparin for VTE prophylaxis?
    Amy Zhou, Anne Winkler, Amir Emamifar, Bryce Gartland, Alexander Duncan, Ana Antun, Martha Arellano, G Allen Tindol, Jerrold H Levy, William A Bornstein, Ira R Horowitz, Hanna Jean Khoury
    Chest. 2012 Nov;142(5):1175-1178